Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ijpharm.2012.08.038
Title: Vitamin e TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects
Authors: Mi, Y.
Zhao, J.
Feng, S.-S. 
Keywords: Anti-cancer drugs
Biodegradable polymers
Cancer nanotechnology
Drug formulation
Nanomedicine
Issue Date: 15-Nov-2012
Source: Mi, Y., Zhao, J., Feng, S.-S. (2012-11-15). Vitamin e TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects. International Journal of Pharmaceutics 438 (1-2) : 98-106. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ijpharm.2012.08.038
Abstract: Double emulsion has been used most often in formulation of hydrophilic drugs by nanoparticles of biodegradable polymers, which has disadvantages such as low drug loading and low drug encapsulation efficiency due to the drug loss in the process. The drug release may be too fast for sustained chemotherapy. We developed in this research a d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) prodrug micelle system with cisplatin as a model hydrophilic drug. We demonstrated that such a system can successfully deliver the model hydrophilic drug with a low critical micelle concentration (CMC) of only 5.01 mg/L, a high drug load of 4.95% (w/w) and a pH-responsive drug release kinetics and higher cellular uptake in comparison with the original drug and the TPGS-cisplatin prodrug itself. The cell viability experiment showed great enhancement of the cisplatin chemotherapy, which is demonstrated by the IC50 value reduced from 3.95, 0.98, 0.19 for cisplatin to 1.36, 0.51, 0.08 μg/mL for the TPGS prodrug micelle formulation after 24, 48, 72 h culture with the HepG2 hepatocarcinoma cells, respectively. Furthermore, such a TPGS prodrug micellar formulation showed significant neuroprotective effects for the cisplatin chemotherapy, which is demonstrated by the greatly increased IC50 value for the SH-SY5Y neuroblast-like cells in comparison between cisplatin and the TPGS prodrug micelle formulation. The TPGS prodrug micelles can also be generalized to become a new strategy for codelivery of hydrophilic and hydrophobic drugs and/or imaging agents. © 2012 Elsevier B.V. All rights reserved.
Source Title: International Journal of Pharmaceutics
URI: http://scholarbank.nus.edu.sg/handle/10635/64786
ISSN: 03785173
DOI: 10.1016/j.ijpharm.2012.08.038
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

34
checked on Dec 6, 2017

WEB OF SCIENCETM
Citations

29
checked on Nov 22, 2017

Page view(s)

31
checked on Dec 10, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.